
Algen Bio is revolutionizing therapeutic drug discovery by leveraging advanced CRISPR gene-modulation and AI. Their proprietary AlgenCRISPR system enables precise gene modulation, powering the…

Algen Bio is revolutionizing therapeutic drug discovery by leveraging advanced CRISPR gene-modulation and AI. Their proprietary AlgenCRISPR system enables precise gene modulation, powering the…
Founded: 2018
Headquarters: San Francisco, California
Focus: CRISPR gene-modulation + deep learning for therapeutic target discovery
Platforms: AlgenCRISPR and AlgenBrain
Employees (approx.): 14
Known investors: Sequoia Capital, Rebel Fund, Viking, Cota Capital, Draper, Illumina Accelerator, Y Combinator
Therapeutic target discovery for complex human diseases using functional genomics and machine learning.
2018
Biotechnology
8900000
Latest funding date and total funding amount provided in company snapshot.
“Backed by institutional and strategic investors including Sequoia Capital, Rebel Fund, Viking Global Investors, Cota Capital, Draper Associates, Illumina Accelerator, and Y Combinator.”
| Company |
|---|
Company Description
Algen is a biotechnology company pioneering next-generation therapies using advanced CRISPR gene modulation and AI-driven drug discovery. A spin-out from the laboratory of Nobel Laureate Dr. Jennifer Doudna, Algen was founded at the forefront of gene modulation innovation. Working as a team at the intersection of functional genomics and AI, the candidate will play a critical role in advancing our discovery programs.
Key Responsibilities Include
Qualifications & Requirements
Preferred
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,300+
New This Week